期刊
NEUROBIOLOGY OF DISEASE
卷 35, 期 3, 页码 348-351出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2009.05.018
关键词
Levodopa; Dyskinesia; Primates; Blood-brain barrier; Imaging; Gadolinium-DTPA
资金
- US National Institutes of Health [P50 NS39793, RR00168]
- Michael Stern Foundation
- Consolidated Anti-Aging Foundation
- Orchard Foundation
It has been suggested, based on rodent studies, that levodopa (L-dopa) induced dyskinesia is associated with a disrupted blood-brain barrier (BBB). We have investigated BBB integrity with in vivo neuroimaging techniques in six 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) lesioned primates exhibiting dopa-induced dyskinesia. Magnetic resonance imaging (MRI) performed before and after injection of Gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) revealed an intact BBB in the basal ganglia showing that L-dopa-induced dyskinesia is not associated with a disrupted BBB in this model. (C) 2009 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据